Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Flowers

Showing results (91-100 of 430) with videos related to

Pageof 43
Sort By:
The Oncologist|June 24, 2025
Impact of sociodemographic determinants on enrollment into contemporary lymphoma clinical trials: a systematic reviewJun Yang Jiang, Ang Li, Alexis Romero, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 17, 2010
Surveillance computed tomography scans for patients with lymphoma: is the risk worth the benefits?Pareen Shenoy, Rajni Sinha, John W Tumeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2007
Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experienceMartha L Arellano, Amelia Langston, Elliott Winton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2019
Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking InfectionMark Aleynick, Judit Svensson-Arvelund, Christopher R Flowers, et al.
Future Oncology (London, England)|August 21, 2015
Next-generation prognostic assessment for diffuse large B-cell lymphomaAshley D Staton, Jean L Koff, Qiushi Chen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Comparing the cost-effectiveness of rituximab maintenance and radioimmunotherapy consolidation versus observation following first-line therapy in patients with follicular lymphomaQiushi Chen, Turgay Ayer, Loretta J Nastoupil, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Microsimulation Modeling in OncologyÇağlar Çağlayan, Hiromi Terawaki, Qiushi Chen, et al.
Future Oncology (London, England)|December 23, 2010
Idiotype vaccine strategies for treatment of follicular lymphomaHemchandra Mahaseth, Joshua D Brody, Rajni Sinha, et al.
Advances in Hematology|December 4, 2010
Clinical, molecular, and environmental risk factors for hodgkin lymphomaAlison Maggioncalda, Neha Malik, Pareen Shenoy, et al.
Cancer|May 7, 2016
Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphomaJonathon B Cohen, Xuesong Han, Ahmedin Jemal, et al.
Pageof 43

Showing results (91-100 of 430) with videos related to

Sort By:
Pageof 43
The Oncologist|June 24, 2025
Impact of sociodemographic determinants on enrollment into contemporary lymphoma clinical trials: a systematic reviewJun Yang Jiang, Ang Li, Alexis Romero, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 17, 2010
Surveillance computed tomography scans for patients with lymphoma: is the risk worth the benefits?Pareen Shenoy, Rajni Sinha, John W Tumeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 16, 2007
Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experienceMartha L Arellano, Amelia Langston, Elliott Winton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2019
Pathogen Molecular Pattern Receptor Agonists: Treating Cancer by Mimicking InfectionMark Aleynick, Judit Svensson-Arvelund, Christopher R Flowers, et al.
Future Oncology (London, England)|August 21, 2015
Next-generation prognostic assessment for diffuse large B-cell lymphomaAshley D Staton, Jean L Koff, Qiushi Chen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Comparing the cost-effectiveness of rituximab maintenance and radioimmunotherapy consolidation versus observation following first-line therapy in patients with follicular lymphomaQiushi Chen, Turgay Ayer, Loretta J Nastoupil, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Microsimulation Modeling in OncologyÇağlar Çağlayan, Hiromi Terawaki, Qiushi Chen, et al.
Future Oncology (London, England)|December 23, 2010
Idiotype vaccine strategies for treatment of follicular lymphomaHemchandra Mahaseth, Joshua D Brody, Rajni Sinha, et al.
Advances in Hematology|December 4, 2010
Clinical, molecular, and environmental risk factors for hodgkin lymphomaAlison Maggioncalda, Neha Malik, Pareen Shenoy, et al.
Cancer|May 7, 2016
Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphomaJonathon B Cohen, Xuesong Han, Ahmedin Jemal, et al.
Pageof 43